Table 1 The association between ARHGEF39 expression and the clinicopathological characteristics
Items | A39+ (n = 62) | A39− (n = 47) | P | |
|---|---|---|---|---|
Age | ||||
<60 | 37 | 21 | 0.12 | |
≥60 | 25 | 26 | ||
Gender | ||||
Male | 43 | 25 | 0.084 | |
Female | 19 | 22 | ||
Tumor size | ||||
≤ 3 cm | 11 | 36 | 0.008 | |
> 3 cm | 32 | 30 | ||
TNM staging | ||||
I-II | 45 | 38 | 0.316 | |
IIIA | 17 | 9 | ||
Regional lymph node metastasis | ||||
No | 33 | 28 | 0.508 | |
Yes | 29 | 19 | ||
Histological differetiation | ||||
Well | 20 | 21 | 0.185 | |
Moderate & Poor | 42 | 26 | ||
Histological type | ||||
Squamous cell cancer | 30 | 17 | 0.202 | |
Adenocarinoma | 32 | 30 | ||
Smoking history | ||||
Never | 14 | 18 | 0.074 | |
Ever | 48 | 29 | ||
